Streptozocin is a type of medicine used to treat cancer. It's made by a type of bacteria. Doctors use it to help kill cancer cells. It can also be used to make diabetic animals for research.
Every report comes from a Lived member, sent anonymously.
Have you tried Streptozocin for Islet Cell Carcinoma?
Streptozocin, sold as Zanosar, is a chemotherapy medicine used for neuroendocrine tumors of the pancreas, also called islet cell tumors. These uncommon cancers grow from the hormone-producing cells of the pancreas and behave quite differently from the more common type of pancreatic cancer. In the US, streptozocin is approved for islet cell cancer that has spread to other parts of the body. Because it can damage the kidneys, it is reserved for disease that is causing symptoms or growing. Tumors that release excess hormones (called functional tumors) and those that do not can both respond. Its safety and effectiveness have not been established in people under 18. Streptozocin is usually given together with another chemotherapy drug, most often fluorouracil (5-FU), and sometimes doxorubicin or capecitabine. It is one of several options for advanced pancreatic neuroendocrine tumors. Others include hormone-blocking injections (somatostatin analogs such as octreotide or lanreotide), targeted pills such as everolimus or sunitinib, a targeted radiation treatment called peptide receptor radionuclide therapy (PRRT), and the chemotherapy pairing of capecitabine and temozolomide. Streptozocin combinations tend to shrink tumors more often than the targeted pills, while those pills more often aim to hold the disease steady. The choice depends on how fast the tumor is growing, symptoms, kidney function and earlier treatment. The original US-made Zanosar has been discontinued. Since 2025, the FDA has allowed a European-made Zanosar to be imported to ease a shortage. It contains the same drug and follows the same dosing schedule.
Streptozocin belongs to a group of chemotherapy drugs called alkylating agents. Once in the bloodstream, it breaks down into reactive compounds that attach to a cell's DNA and link its strands together. A cell with badly damaged DNA cannot copy itself properly and dies, which is how the drug slows or shrinks a tumor. Part of the streptozocin molecule is a sugar (glucose) unit. This makes it milder on the bone marrow than related drugs, but the drug also harms the insulin-making cells of the pancreas, which is why it can affect blood sugar. In laboratory research, high doses are used to cause diabetes in animals. The kidneys clear the drug and its breakdown products from the body, and they bear most of its toxicity.
Streptozocin is given only through a vein (intravenously, or IV) in a hospital or infusion center, under the supervision of a doctor experienced with chemotherapy. The dose is calculated from body size and adjusted for kidney function. Two schedules are common. In one, an infusion is given on five days in a row, and that course is repeated every six weeks. In the other, larger single infusions are given weekly (the US schedule) or, after a first five-day course, every three weeks (the European schedule). With the imported Zanosar, each infusion runs between 30 minutes and 4 hours, and a large volume of IV fluid is given beforehand to help protect the kidneys. Anti-nausea medicine is given before each dose. Follow the care team's advice about drinking fluids during treatment. Streptozocin can damage tissue if it leaks out of the vein. Tell the nurse right away about burning, pain or swelling at the IV site during an infusion. Doses may be delayed, lowered or stopped depending on blood and kidney test results.
Nausea and vomiting are the most common side effects. In early studies they affected most people, but modern anti-nausea medicines have made severe vomiting much less frequent. It can still occasionally force treatment to stop. Diarrhea, tiredness, low mood and sluggishness can also occur. Some people feel confused or drowsy, so avoid driving until you know how the drug affects you. Mild, temporary rises in liver enzymes on blood tests are common and rarely cause symptoms. The kidneys are the main concern. Streptozocin can cause kidney damage that usually builds with each course and can become severe or even fatal, although it can also appear after the first dose. An early sign is protein leaking into the urine, which routine tests can find before symptoms appear. Call the care team right away about decreased urination, new swelling of the face, hands, feet, ankles or legs, or unusual tiredness or weakness. Blood counts usually drop only mildly, but serious drops can happen, most often when streptozocin is combined with other chemotherapy. Call the care team right away about fever, chills, sore throat or other signs of infection, unusual bleeding or bruising, black or bloody stools, or vomit that contains blood or looks like coffee grounds. Streptozocin can also affect blood sugar. Mild changes in how the body handles glucose are usually reversible. Call the care team right away about signs of low blood sugar (shakiness, sweating, sudden hunger or confusion) or of high blood sugar (unusual thirst and frequent urination). A seizure needs emergency care. Pain, redness, swelling, blisters or sores where the drug was given also need a prompt call.
Streptozocin should not be combined with other medicines that can harm the kidneys. Examples include nonsteroidal anti-inflammatory pain relievers (NSAIDs) such as ibuprofen (Advil, Motrin) and naproxen (Aleve), aminoglycoside antibiotics such as gentamicin, the chemotherapy drug cisplatin, and the iodine-based contrast dye used for some scans. Check with the oncology team before using any of them. Before each course, the oncology team and pharmacist should review every prescription, over-the-counter medicine and supplement. People with existing kidney disease face a higher risk. The European label does not allow streptozocin when kidney function is severely reduced, measured as a glomerular filtration rate (GFR, an estimate of how well the kidneys filter blood) below 30. It halves the dose when GFR is between 45 and 60, and calls for a careful decision with a kidney specialist between 30 and 45. Lower GFR numbers mean weaker kidney function. Live vaccines, which contain a weakened form of a germ, should not be given during treatment, because a chemotherapy-weakened immune system can let the vaccine cause a serious infection. Inactivated vaccines can be given but may work less well. People taking warfarin, a blood thinner, need more frequent INR checks (the international normalized ratio, a blood test of clotting time). Streptozocin may harm a developing baby. Effective contraception is advised during treatment. The European label advises continuing it for 30 days afterward for women and 90 days for men. Breastfeeding should be stopped during treatment. Animal studies showed reduced fertility in both males and females, so ask about fertility preservation before starting (for men, this can include banking sperm). Streptozocin caused cancer in laboratory animals. Rare cases of blood cancers (myelodysplastic syndrome or acute myeloid leukemia) have been reported in people who had streptozocin and later received radionuclide therapy.
Treatment is given in cycles, with rest periods between courses so the body can recover. Expect blood and urine tests before and between courses, including kidney tests (creatinine, a blood waste product used to estimate how well the kidneys filter, and urine protein), blood counts, liver tests and blood sugar. If kidney results worsen, the doctor may lower the dose, delay treatment or stop it. That is a normal part of using this drug safely, not a sign that something was done wrong. Whether the treatment is working is judged with scans that show if tumors are shrinking or holding steady. For tumors that release hormones, blood tests of those hormones or tumor markers can show a response too. In studies, tumors shrank meaningfully in roughly 20 to 40 percent of people treated with streptozocin combinations. Much of that evidence comes from older or small studies, and results vary from person to person. There is no fixed length of treatment. Courses usually continue while they help and side effects stay manageable, and the best length of ongoing treatment has not been established.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Streptozocin, what you've noticed, or ask the community a question.